Blog

Four common but critical questions for emerging biotech organizations establishing a pharmacovigilance (PV) organization.

This checklist outlines key milestones and considerations for sites and sponsors in the clinical trial study startup process.

Explore the benefits of pre-screening potential participants before they move on to the informed consent process.

Like other IRBs, Advarra is subject to inspections from time to time. What standards are we measured against?

Both sites and sponsors must consider how DCT funding and legal structures can impact sites and the study itself.

Advarra expert Steffen Engel answers questions from the webinar, Stepwise Implementation of a Clinical Quality Management System.

Learn about the benefits to integrating with technology systems such as email, eIRB, CTMS, and other eReg platforms as you increase ROI.

Investing in those who lead your clinical trial associates' (CTAs) is essential to building a thriving clinical research workforce.

While we usually think of our leadership roles as impact roles, it’s time to rethink highly impactful entry-level roles

Explore cross-industry feedback from stakeholders to better investigate key research workflows.

This blog provides a beginner’s overview of what the pre-IND meeting is and how to prepare for one.

This blog focuses on understanding how the clinical trial associate (CTA) role fits within the clinical research organization.